“Never was so much owed by so many to so few,” the infamous quote attributed to wartime leader Winston Churchill, referring to the pilots that engaged in the Battle of Britain, has never been more applicable to a modern situation than the one we are facing globally today. Indeed, the world is at war again. This time, the enemy is a mutating virus that has brought industry and education to a standstill. This time, “the few” we must thank for standing up to the enemy, and giving the world back its normalcy, are the chemists, scientists and manufacturers behind the COVID-19 vaccines that have been approved and are still in development.
At War With A Pandemic: Manufacturing For Our Lives
The rapid development of a vaccine to fight COVID-19 is an effort that will be discussed and admired for centuries to come. The effort to make and deliver the vaccines to those who are most at risk is a battle all of its own. Two manufacturers talk to In Vivo about managing roll out strategies when the whole world is watching.
